CVS Health Corporation (NYSE:CVS) is named one of the 20 Best Performing Dividend Stocks in 2025. JPMorgan highlights CVS as a top pick in health care services due to a remarkable turnaround, with the stock gaining 80.5% this year. Financial performance has improved, with third-quarter revenue reaching $102.9 billion.

Analyst Lisa Gill sets a $101 price target for CVS, reflecting confidence in recent operational changes. CVS outlined a plan last year to deliver at least $2 billion in cost savings over several years, which is gaining traction. The company operates as a healthcare innovation company with a broad footprint spanning various healthcare services.

While CVS shows promise as an investment, some AI stocks may offer greater upside potential. For investors looking for undervalued AI stocks, an analysis of the best short-term AI stock is recommended. CVS continues to show signs of growth and improvement, making it a stock to watch in the healthcare sector.

Read more at Yahoo Finance: JPMorgan Names CVS a Top Pick as Turnaround Gains Traction